General Information of the Compound
Compound ID
CP0138332
Compound Name
US9243020, 19
    Show/Hide
Synonyms
(3AR,5S,6S,7R,7aR,E)-5-(difluoromethyl)-2-(ethylimino)hexahydro-5H-pyrano[3,2-d]thiazole-6,7-diol
(3aR,5S,6S,7R,7aR)-5-(difluoromethyl)-2-(ethylamino)-3a,6,7,7a-tetrahydro-5H-pyrano[3,2-d]thiazole-6,7-diol
(3aR,5S,6S,7R,7aR)-5-(difluoromethyl)-2-(ethylamino)-5,6,7,7a-tetrahydro-3aH-pyrano[3,2-d][1,3]thiazole-6,7-diol
(3aR,5S,6S,7R,7aR)-5-(difluoromethyl)-2-ethylimino-1,3a,5,6,7,7a-hexahydropyrano[3,2-d][1,3]thiazole-6,7-diol
1382799-40-7
BDBM205424
CHEMBL4111094
GTPL10508
MK-8719
MK8719
Q66885447
SCHEMBL9956073
US9243020, 19
compound 42 [PMID: 31487175]
s8890
    Show/Hide
Structure
Formula
C9H14F2N2O3S
Molecular Weight
268.285
Canonical SMILES
CCNC1=N[C@H]2[C@H](O[C@H](C(F)F)[C@@H](O)[C@@H]2O)S1
    Show/Hide
InChI
InChI=1S/C9H14F2N2O3S/c1-2-12-9-13-3-4(14)5(15)6(7(10)11)16-8(3)17-9/h3-8,14-15H,2H2,1H3,(H,12,13)/t3-,4-,5+,6+,8-/m1/s1
    Show/Hide
InChIKey
UDQTXCHQKHIQMH-KYGLGHNPSA-N
Physicochemical Property
logP
-0.2209
Rotatable Bonds
2
Heavy Atom Count
17
Polar Areas
74.08
Hydrogen Bond Donor Count
3
Hydrogen Bond Acceptor Count
6
Complexity
17

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 57521038
SID: 137278503
ChEMBL ID
CHEMBL4111094
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT06114, Protein O-GlcNAcase
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000868 PC12 Rattus norvegicus (Rat)  1
1
EC50 = 52.7 nM
   TI
   LI
   LO
   TS
Clinical Information about the Compound
Drug 1 ( MK-8719 )
Drug Name MK-8719
Company Alectos
Indication
Progressive supranuclear palsy
Phase 1
Target(s)
Beta-N-acetylhexosaminidase (OGA)
Inhibitor